Baltimore-LASIK presents a challenge to normal tear film dynamics, and some patients may be affected by prolonged neurotrophic epitheliopathy.
GenTeal PF, the newest addition to Novartis Ophthalmics' line of dry eye products, is an appropriate choice for patients who must use a true preservative-free drop because they cannot tolerate even the transient preservatives found in some other artificial tears, according to Marguerite McDonald, MD, FACS, clinical professor of ophthalmology, Tulane University, New Orleans.
Jacksonville, FL-In any disease, the differential diagnosis is paramount to ensure proper treatment. This is also true for patients who complain of dry eye before and after LASIK. Arun C. Gulani, MD, created a decision pyramid that allows him to get to the root of complaints of dry in his patients.
San Francisco-Confocal microscopy is an excellent supplement to the slit-lamp examination for identifying suspected pathology by viewing specific layers of the anterior segment, according to Herbert E. Kaufman, MD, who spoke during the Innovator's Session at the American Society of Cataract and Refractive Surgery Annual Meeting.
CA-The FDA approval of gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) marks a milestone as the first fourth-generation fluoroquinolone to enter the ophthalmic market. The therapy for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria also has a unique mechanism to prevent development of antibiotic resistance, according to Allergan.
A craniocervical arterial dissection usually results from a tear in the intimal arterial layer. This tear allows the formation of a false lumen containing a clot, which can lead to thromboembolic complications (stroke). If the dissection is subintimal, stenosis of the artery is the likely end result. If it is subadventitial, the result is a "pseudo-aneurysm" (Figure 1).
London-Routine testing for color vision deficiency is not a reliable method to detect digoxin toxicity in patients taking the drug for heart failure or other cardiac problems, said J.G. Lawrenson, PhD.
Boston-The mast-cell stabilizer pemirolast potassium 0.1% (Alamast, Santen) is a safe, comfortable, and effective agent for preventing and relieving ocular itching of seasonal allergic conjunctivitis throughout the allergy season, according to a pooled analysis of data from phase III trials.
Tampa, FL-Loteprednol etabonate ophthalmic suspension 0.2% (Alrex, Bausch & Lomb Pharmaceuticals and Pharmos Corp.), the first corticosteroid specifically designed for signs and symptoms of seasonal allergic conjunctivitis (SAC), is safe for long-term use, according to a recent multicenter study.
This year's fierce winter is now about to bring a big dose of misery to the 60 million Americans who suffer from seasonal allergies. Experts predict a fast-peaking, intense spring allergy season. Moisture accumulated from heavy snow and excessive rain has nurtured mold, and will fuel tree-pollen production-all of which will trigger an early and severe allergy season.